Corrigendum: Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma

Dongshan Chen,Chen Zhang,Yuanwei Zang,Wei Wang,Jiandong Zhang

DOI: https://doi.org/10.3389/fgene.2024.1440802

IF: 3.7

2024-06-27

Frontiers in Genetics

Abstract:This article is a correction to: Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma

genetics & heredity

What problem does this paper attempt to address?

Corrigendum: A New Prognostic Risk Score: Based on the Analysis of Autophagy-Related Genes and Renal Cell Carcinoma

Minxin He,Mingrui Li,Yawen Guan,Ziyan Wan,Jie Tian,Fangshi Xu,Haibin Zhou,Mengchun Gao,Hang Bi,Tie Chong

DOI: https://doi.org/10.3389/fgene.2022.904512

IF: 3.7

2022-01-01

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2021.820154.].
Corrigendum to “system Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma”

Jun Xu,Yongjun Guan,Zhendong Qiu,Xin Zhang,Zi Liu,Yu Zhou,Chen,Jia Yu,Yi Chao Zhang,Weixing Wang

DOI: https://doi.org/10.1155/2022/9875295

2022-01-01

Oxidative Medicine and Cellular Longevity

Abstract:[This corrects the article DOI: 10.1155/2021/6485871.].
Corrigendum: Identification of Microtube-Associated Biomarkers in Diffuse Large B-cell Lymphoma and Prognosis Prediction.

Wenqi Wu,Su Liu,Linyan Tian,Cheng Li,Yanan Jiang,Jinhuan Wang,Yangyang Lv,Jing Guo,Donghui Xing,Yixin Zhai,Huimeng Sun,Yuhang Li,Luying Zhang,Xiang He,Kaiping Luo,Hongjie Zhan,Zhigang Zhao

DOI: https://doi.org/10.3389/fgene.2023.1180076

IF: 3.7

2023-01-01

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1092678.].
Corrigendum: Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer

Yang He,Yongxin Wu,Zhe Liu,Boping Li,Ning Jiang,Peng Xu,Abai Xu

DOI: https://doi.org/10.3389/fgene.2022.880633

IF: 3.7

2022-05-17

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2021.694777.].

genetics & heredity
Correction: Prognostic and Clinicopathological Value of P53 Expression in Renal Cell Carcinoma: a Meta-Analysis

Zhun Wang,Shuanghe Peng,Ning Jiang,Aixiang Wang,Shuguang Liu,Hui Xie,Linpei Guo,Qiliang Cai,Yuanjie Niu

DOI: https://doi.org/10.18632/oncotarget.26394

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.21971.].
Correction to: ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma

Weipu Mao,Keyi Wang,Bin Xu,Hui Zhang,Si Sun,Qiang Hu,Lei Zhang,Chunhui Liu,Shuqiu Chen,Jianping Wu,Ming Chen,Wei Li,Bo Peng

DOI: https://doi.org/10.1186/s12943-021-01459-8

IF: 37.3

2021-12-01

Molecular Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology,biochemistry & molecular biology
Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

TingAn Wang,HuaGe Zhong,YuZhou Qin,WeiYuan Wei,Zhao Li,MingWei Huang,XiaoLing Luo

DOI: https://doi.org/10.1155/2021/3179693

2021-02-09

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2020/3575038.].

biotechnology & applied microbiology,medicine, research & experimental
Corrigendum: A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer

Peijie Chen,Yuting Gao,Si Ouyang,Li Wei,Min Zhou,Hua You,Yao Wang

DOI: https://doi.org/10.3389/fphar.2021.723153

IF: 5.6

2021-08-25

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.585255.].

pharmacology & pharmacy
Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy

Yangyang Guo,Kenan Cen,Qiaoqiao Chen,Ying Dai,Yifeng Mai,Kai Hong

DOI: https://doi.org/10.3389/fimmu.2023.1229541

IF: 7.3

2023-06-05

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1128390.].

immunology
Corrigendum: Association of Dynamic Changes in Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Small Cell Lung Cancer

Yuzhong Chen,Shaodi Wen,Jingwei Xia,Xiaoyue Du,Yuan Wu,Banzhou Pan,Wei Zhu,Bo Shen

DOI: https://doi.org/10.3389/fimmu.2021.713268

IF: 7.3

2021-06-07

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.672271.].

immunology
Corrigendum: Case report: Long remission and survival following immunotherapy in a case of pulmonary pleomorphic carcinoma

Tongshan Wang,Muyang Chen,Anpeng Wang,Hao Zhang

DOI: https://doi.org/10.3389/fimmu.2024.1530843

IF: 7.3

2024-12-03

Frontiers in Immunology

Abstract:This article is a correction to: Case Report: Long Remission and Survival Following Immunotherapy in a Case of Pulmonary Pleomorphic Carcinoma

immunology
Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Yicong Yao,Yi Wang,Denglong Wu,Baoying Hu

DOI: https://doi.org/10.3389/fonc.2021.731942

IF: 4.7

2021-07-21

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.666418.].

oncology
Corrigendum: Establishment and Validation of Prognostic Nomograms for Patients with Parotid Gland Adenocarcinoma Not Otherwise Specified: a SEER Analysis from 2004 to 2016.

Zi-Meng Wang,Zuo-Lin Xiang

DOI: https://doi.org/10.3389/fsurg.2023.1341579

IF: 1.8

2023-01-01

Frontiers in Surgery

Abstract:[This corrects the article DOI: 10.3389/fsurg.2021.799452.].
Corrigendum to “endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications”

Shuo Wang,Chao Zhang,Jina Wang,Cheng Yang,Ming Xu,Ruiming Rong,Tongyu Zhu,Dong Zhu

DOI: https://doi.org/10.1155/2019/9691679

IF: 4.4929

2019-01-01

Journal of Immunology Research

Abstract:[This corrects the article DOI: 10.1155/2017/8746303.].
Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”

Bi-Cheng Wang,Bo-Ya Xiao,Peng-Cheng Li,Bo-Hua Kuang,Wang-Bing Chen,Pin-Dong Li,Guo-He Lin,Quentin Liu

DOI: https://doi.org/10.1155/2021/3735726

IF: 4.501

2021-02-25

Journal of Oncology

Abstract:[This corrects the article DOI: 10.1155/2020/2368164.].

oncology
Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Si Liu,Honglan Zhou,Gang Wang,Xin Lian

DOI: https://doi.org/10.3389/fcell.2023.1216783

IF: 5.5

2023-06-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.709490.].

cell biology,developmental biology
Correction: Corrigendum: Long Intergenic Non-Coding RNA 271 is Predictive of a Poorer Prognosis of Papillary Thyroid Cancer

Ben Ma,Tian Liao,Duo Wen,Chuanpeng Dong,Li Zhou,Shuwen Yang,Yu Wang,Qinghai Ji

DOI: https://doi.org/10.1038/srep42321

IF: 4.6

2017-01-01

Scientific Reports

Abstract:Scientific Reports 6: Article number: 36973; published online: 11 November 2016; updated: 09 February 2017 This Article contains errors in Table 1 and Table 4. The correct Table 1 and Table 4 appear below as Table 1 and Table 2 respectively.
Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Anli Yang,Ying Zhou,Yanan Kong,Xiaoli Wei,Feng Ye,Lijuan Zhang,Xian Zhong,Mingyue Li,Shilin Lu,Xin An,Weikai Xiao

DOI: https://doi.org/10.3389/fimmu.2024.1372991

IF: 7.3

2024-01-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.704557.].

immunology
Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

Haiyang Zhao,Kexin Luo,Meihan Liu,Yuanze Cai,Siman Liu,Shijuan Li,Yongsheng Zhao,Hongpan Zhang

DOI: https://doi.org/10.3389/fgene.2024.1531321

IF: 3.7

2024-12-04

Frontiers in Genetics

Abstract:This article is a correction to: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

genetics & heredity
Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma

Tingting Deng,Yang Liu,Jialang Zhuang,Yizhe Tang,Qin Huo

DOI: https://doi.org/10.3389/fonc.2022.979968

IF: 4.7

2022-08-22

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.632042.].

oncology

Corrigendum: Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma

Corrigendum: A New Prognostic Risk Score: Based on the Analysis of Autophagy-Related Genes and Renal Cell Carcinoma

Corrigendum to “system Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma”

Corrigendum: Identification of Microtube-Associated Biomarkers in Diffuse Large B-cell Lymphoma and Prognosis Prediction.

Corrigendum: Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer

Correction: Prognostic and Clinicopathological Value of P53 Expression in Renal Cell Carcinoma: a Meta-Analysis

Correction to: ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

Corrigendum: A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer

Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy

Corrigendum: Association of Dynamic Changes in Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Small Cell Lung Cancer

Corrigendum: Case report: Long remission and survival following immunotherapy in a case of pulmonary pleomorphic carcinoma

Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Corrigendum: Establishment and Validation of Prognostic Nomograms for Patients with Parotid Gland Adenocarcinoma Not Otherwise Specified: a SEER Analysis from 2004 to 2016.

Corrigendum to “endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications”

Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”

Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Correction: Corrigendum: Long Intergenic Non-Coding RNA 271 is Predictive of a Poorer Prognosis of Papillary Thyroid Cancer

Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma